PURAFIL(R*) SP MEDIA

SECTION 2: Hazards identification

ALUMINUM OXIDE ACTIVATED 1333-84-2* </=64 (NON-FIBROUS) ALUMINAS; ACTIVATED AND AMORPHOUS ALUMINAS WATER DIHYDROGEN 7732-18-5 </=35 OXIDE PROPRIETARY </=24 INGREDIENT SODIUM PERMANGANIC 10101-50-5 >/=12 PERMANGANATE ACID SODIUM SALT SOLUTION *FOR TSCA INVENTORY REPORTING PURPOSES, CAS NO. 1344-28-1 WAS ASSIGNED FOR ALL FORMS OF ALUMINUM OXIDE INSTEAD OF THE CAS NO. 1333-84-2 AS INDICATED ABOVE. COMPOSITION COMMENTS: FOR THE FULL TEXT OF R PHRASES MENTIONED IN THIS SECTION, SEE SECTION 16. 3. HAZARDS IDENTIFICATION MOST IMPORTANT HAZARDS: IF CRUSHED OR HANDLED EXTENSIVELY, DUST MAY EVOLVE AND CAN BE IRRITATING TO THE EYES, SKIN, AND RESPIRATORY TRACT. ADVERSE HUMAN HEALTH EFFECTS: THE FOLLOWING MEDICAL CONDITIONS MAY BE AGGRAVATED BY EXPOSURE TO THE PRODUCT: ASTHMA, CHRONIC LUNG DISEASE, AND SKIN RASHES. IF THE PRODUCT CONTACTS THE SKIN WITH WATER, IT MAY LEAVE A STAIN OF INSOLUBLE PRODUCTS ON THE SKIN. THIS STAIN WILL BE WASHED AWAY/RUBBED OFF OVER A PERIOD OF TIME (HOURS TO DAYS). ENVIRONMENTAL EFFECTS: IF CONTACTED BY WATER, THE SODIUM PERMANGANATE MAY LEACH OUT AND THE WATER MAY TURN PINK TO PURPLE IN COLOR. SODIUM BISULFITE WILL CLARIFY THE WATER (BY CHEMICAL REDUCTION), BUT WILL GIVE OFF SULFUR DIOXIDE AND SHOULD ONLY BE USED IN WELL VENTILATED AREAS. LOCAL REGULATIONS SHOULD ALWAYS BE CONSULTED AND FOLLOWED. EMERGENCY OVERVIEW: INHALATION: MOVE TO FRESH AIR. IF BREATHING DIFFICULTY OCCURS OR PERSISTS, SEEK MEDICAL ATTENTION. SKIN CONTACT: WASH AREA WITH LARGE QUANTITIES OF WATER. EYE CONTACT: FLUSH WITH LARGE QUANTITIES OF WATER. SEEK MEDICAL ATTENTION. INGESTION: SEEK MEDICAL ATTENTION. OTHER INFORMATION: THIS MEDIA IS CLASSIFIED BY THE MANUFACTURER FOR HEALTH EFFECTS ACCORDING TO EU DIRECTIVE 1999/45/EC WITH Xi; R36/37/38.